Science & ResearchAug 28, 2026
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk.
Current U.S. and European guidelines recommend oral anticoagulation as a class IIa indication in patients with atrial fibrillation at intermediate risk for stroke; however, evidence from randomized trials is needed. We conducted a multic…
Current U.S. and European guidelines recommend oral anticoagulation as a class IIa indication in patients with atrial fibrillation at intermediate risk for stroke; however, evidence from randomized trials is needed. We conducted a multicenter, open-label, adjudicator-masked…
Sign in to learn & save →
The frontier is open to all. Sign in to learn this from first principles and save it to your knowledge base.